Myeloid Leukemia: Clinical Trials

2 trials for Myeloid Leukemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown. 2 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Unknown 2
Phase 11Unknown 1
Phase 31Unknown 1

Follow Myeloid Leukemia: new trials by email Literature Review of Myeloid Leukemia trials Research Report on Myeloid Leukemia

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies
CAR-T cell immunotherapy - B-cell Acute Lymphoblastic Leukemia, Lymphoma
Phase 1 / Phase 2UnknownShenzhen BinDeBio Ltd.732018-03-012019-12-11
Therapy-Optimization Trial for the Treatment of Acute Myeloid Leukemias (AML) in Children and Adolescents
Anthracyclines, liposomal daunorubicin, 2-CDA - Myeloid Leukemia
Phase 2 / Phase 3UnknownUniversity Hospital Muenster5502004-03-012012-05-23

Narrower conditions

Leukemia, Myeloid (2)  ·  Burkitt Lymphoma (1)  ·  Carcinoma, Hepatocellular (1)  ·  Carcinoma, Renal Cell (1)  ·  Colorectal Neoplasms (1)  ·  Esophageal Neoplasms (1)  ·  Glioma (1)  ·  Leukemia (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Lung Neoplasms (1)  ·  Lymphoma (1)  ·  Melanoma (1)  ·  Mesothelioma (1)  ·  Multiple Myeloma (1)  ·  Ovarian Neoplasms (1)

Broader conditions

Hematologic Diseases (2)  ·  Hemic and Lymphatic Diseases (2)  ·  Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Adenocarcinoma (1)  ·  Adenoma (1)  ·  Adnexal Diseases (1)  ·  Blood Protein Disorders (1)  ·  Carcinoma (1)  ·  Cardiovascular Diseases (1)  ·  Colonic Diseases (1)  ·  DNA Virus Infections (1)  ·  Digestive System Diseases (1)  ·  Digestive System Neoplasms (1)  ·  Endocrine Gland Neoplasms (1)

Interventions

Anthracyclines (1)  ·  Cladribine (1)  ·  Daunorubicin (1)  ·  Idarubicin (1)  ·  Immunotherapy, Adoptive (1)

Sponsors

Shenzhen BinDeBio Ltd. (1)  ·  University Hospital Muenster (1)

Countries

China (1)  ·  Germany (1)

Top investigators

Dirk Reinhardt, Prof. Dr. med. (1)  ·  Ursula Creutzig, Prof. Dr. med. (1)

Results publications

PMID 18083847, PMID 18182574, PMID 21480469, PMID 23704089, PMID 26814618, PMID 27269945, PMID 40803346